The blood products company is still looking like a good buy. The post Morgan Stanley just upgraded their CSL share price ...

Only 50 BMW 3.0 CSLs were built, and each was a collector car before it turned a wheel. That is why car No. 28 matters. Broad ...

Nestled into the pines of southern Wake County is the largest cell-based flu vaccine maker in the world. Why it matters: CSL ...

CSL Canada has expanded public reimbursement for ANDEMBRY® (garadacimab), its once-monthly hereditary angioedema prophylaxis, ...

The Australian pharma company believes the drug will be an important therapeutic option to improve kidney function.

CSL Ltd (ASX: CSL) has announced a major new drug development partnership. Does the deal make the healthcare share worth buying?

Australian fund managers piled into the one-time blue-chip health giant last month, with the stock now the top position held by local equity fund managers.

CSL Ltd. agreed to pay as much as $1.6 billion to jointly develop and sell an experimental treatment for rare kidney and liver diseases, expanding the Australian biotech company’s push into kidney ...

Five analyst houses put the 12-month consensus target for CSL at EUR 113.10 on October 14, 2026, according to Boerse Express.

CSL Group, the leading global provider of Critical Connectivity®, has acquired SIMPL Wireless, the US-based IoT eSIM ...